Literature DB >> 19361627

Twenty years' experience of steroids in infantile hemangioma--a developing country's perspective.

Anand Pandey1, Ajay Narayan Gangopadhyay, Saroj Chooramani Gopal, Vijayendra Kumar, Shiv Prasad Sharma, Dinesh Kumar Gupta, Chandrasen Kumar Sinha.   

Abstract

BACKGROUND: Hemangioma is a common vascular tumor. Though it involutes spontaneously, results are unpredictable. Steroid therapy is an effective mode of its regression. We present our experience of largest series and possible recommendations for treatment.
MATERIALS AND METHODS: A total of 2398 patients were treated during the study period of 20 years. They were given oral prednisolone, intralesional triamcinolone, or combination of both as per the protocol and followed for the response. Response to the treatment was graded as excellent, good, poor, or no response.
RESULTS: The male-to-female ratio was 1:2.3. In 81% of patients, hemangioma was noticed within first month of life. The commonest site of involvement was head and neck (57%). The commonest clinical presentation was discoloration and swelling. Mean age and size were 8.43 +/- 7.04 months and 23.64 +/- 20.13 cm(2). Response rate was highest for superficial type using any modality of treatment. Patients younger than 1 year showed better response (90.3%) in comparison with children older than 1 year (80.8%). The specific complications occurring were infections in 249 (12.4%), cushingoid facies and growth delay in 62 (3.1%), and hypertension in 51 (2.5%) patients.
CONCLUSION: Steroid therapy either oral or intralesional as per the requirement is an easy and safe modality. Results are good to satisfactory in most patients. The complications are minimal. If treatment is needed, it should be used as a first-line therapy, especially when cost is an important concern.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19361627     DOI: 10.1016/j.jpedsurg.2008.10.038

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  12 in total

1.  Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma.

Authors:  Mohamed M D Aly; Alaa F Hamza; Hesham M Abdel Kader; Hatem A Saafan; Mohamed S Ghazy; Iman A Ragab
Journal:  Eur J Pediatr       Date:  2015-05-16       Impact factor: 3.183

2.  Japanese clinical practice guidelines for vascular anomalies 2017.

Authors:  Hidefumi Mimura; Sadanori Akita; Akihiro Fujino; Masatoshi Jinnin; Mine Ozaki; Keigo Osuga; Hiroki Nakaoka; Eiichi Morii; Akira Kuramochi; Yoko Aoki; Yasunori Arai; Noriko Aramaki; Masanori Inoue; Yuki Iwashina; Tadashi Iwanaka; Shigeru Ueno; Akihiro Umezawa; Michio Ozeki; Junko Ochi; Yoshiaki Kinoshita; Masakazu Kurita; Shien Seike; Nobuyuki Takakura; Masataka Takahashi; Takao Tachibana; Kumiko Chuman; Shuji Nagata; Mitsunaga Narushima; Yasunari Niimi; Shunsuke Nosaka; Taiki Nozaki; Kazuki Hashimoto; Ayato Hayashi; Satoshi Hirakawa; Atsuko Fujikawa; Yumiko Hori; Kentaro Matsuoka; Hideki Mori; Yuki Yamamoto; Shunsuke Yuzuriha; Naoaki Rikihisa; Shoji Watanabe; Shinichi Watanabe; Tatsuo Kuroda; Shunsuke Sugawara; Kosuke Ishikawa; Satoru Sasaki
Journal:  Jpn J Radiol       Date:  2020-04       Impact factor: 2.374

3.  Japanese Clinical Practice Guidelines for Vascular Anomalies 2017.

Authors:  Hidefumi Mimura; Sadanori Akita; Akihiro Fujino; Masatoshi Jinnin; Mine Ozaki; Keigo Osuga; Hiroki Nakaoka; Eiichi Morii; Akira Kuramochi; Yoko Aoki; Yasunori Arai; Noriko Aramaki; Masanori Inoue; Yuki Iwashina; Tadashi Iwanaka; Shigeru Ueno; Akihiro Umezawa; Michio Ozeki; Junko Ochi; Yoshiaki Kinoshita; Masakazu Kurita; Shien Seike; Nobuyuki Takakura; Masataka Takahashi; Takao Tachibana; Kumiko Chuman; Shuji Nagata; Mitsunaga Narushima; Yasunari Niimi; Shunsuke Nosaka; Taiki Nozaki; Kazuki Hashimoto; Ayato Hayashi; Satoshi Hirakawa; Atsuko Fujikawa; Yumiko Hori; Kentaro Matsuoka; Hideki Mori; Yuki Yamamoto; Shunsuke Yuzuriha; Naoaki Rikihisa; Shoji Watanabe; Shinichi Watanabe; Tatsuo Kuroda; Shunsuke Sugawara; Kosuke Ishikawa; Satoru Sasaki
Journal:  J Dermatol       Date:  2020-03-22       Impact factor: 4.005

4.  Effectiveness and Safety of Oral Propranolol versus Other Treatments for Infantile Hemangiomas: A Meta-Analysis.

Authors:  Xiaohan Liu; Xinhua Qu; Jiawei Zheng; Ling Zhang
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

5.  Re: Propranolol for infantile haemangiomas: Early experience from a tertiary center.

Authors:  Anand Pandey; Shailendra P Singh; Rajesh Verma; Vipin Gupta
Journal:  J Cutan Aesthet Surg       Date:  2014-04

Review 6.  Systematic Review of the Toxicity of Long-Course Oral Corticosteroids in Children.

Authors:  Fahad Aljebab; Imti Choonara; Sharon Conroy
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

Review 7.  Genetic investigation of childhood vascular tumor biology reveals pathways for therapeutic intervention.

Authors:  Shayan Cheraghlou; Young Lim; Keith Choate
Journal:  F1000Res       Date:  2019-04-30

8.  Proposal for future diagnosis and management of vascular tumors by using automatic software for image processing and statistic prediction.

Authors:  M D Popescu; L Draghici; I Secheli; M Secheli; M Codrescu; I Draghici
Journal:  J Med Life       Date:  2015 Jan-Mar

9.  Masterly inactivity in infantile haemangioma: Does it still hold relevance?

Authors:  Nitin Sharma; Minu Bajpai; Ajay Verma; Shasanka Shekhar Panda; Amit K Singh
Journal:  Afr J Paediatr Surg       Date:  2015 Jul-Sep

Review 10.  Clinical Outcomes for Systemic Corticosteroids Versus Vincristine in Treating Kaposiform Hemangioendothelioma and Tufted Angioma.

Authors:  Xiaohan Liu; Jiaying Li; Xinhua Qu; Weili Yan; Ling Zhang; Shanyong Zhang; Chi Yang; Jiawei Zheng
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.